210 related articles for article (PubMed ID: 23031192)
1. Diabetes is associated with lower global cognitive function in schizophrenia.
Takayanagi Y; Cascella NG; Sawa A; Eaton WW
Schizophr Res; 2012 Dec; 142(1-3):183-7. PubMed ID: 23031192
[TBL] [Abstract][Full Text] [Related]
2. Relationship between metabolic syndrome and cognition in patients with schizophrenia.
Lindenmayer JP; Khan A; Kaushik S; Thanju A; Praveen R; Hoffman L; Cherath L; Valdez G; Wance D
Schizophr Res; 2012 Dec; 142(1-3):171-6. PubMed ID: 23106932
[TBL] [Abstract][Full Text] [Related]
3. Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis.
Potvin S; Joyal CC; Pelletier J; Stip E
Schizophr Res; 2008 Mar; 100(1-3):242-51. PubMed ID: 17614260
[TBL] [Abstract][Full Text] [Related]
4. General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia.
Réthelyi JM; Czobor P; Polgár P; Mersich B; Bálint S; Jekkel E; Magyar K; Mészáros A; Fábián A; Bitter I
Eur Arch Psychiatry Clin Neurosci; 2012 Mar; 262(2):107-15. PubMed ID: 21792534
[TBL] [Abstract][Full Text] [Related]
5. Impact of social anxiety on social cognition and functioning in patients with recent-onset schizophrenia spectrum disorders.
Achim AM; Ouellet R; Lavoie MA; Vallières C; Jackson PL; Roy MA
Schizophr Res; 2013 Apr; 145(1-3):75-81. PubMed ID: 23415473
[TBL] [Abstract][Full Text] [Related]
6. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
7. A case control study of association between cognition and functional capacity in schizophrenia.
Narayanan SS; Bhatia T; Velligan DI; Nimgaonkar VL; Deshpande SN
Schizophr Res; 2015 Dec; 169(1-3):165-168. PubMed ID: 26527248
[TBL] [Abstract][Full Text] [Related]
8. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
[TBL] [Abstract][Full Text] [Related]
9. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
Huguelet P; Nicastro R; Zanello A
Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
[TBL] [Abstract][Full Text] [Related]
10. Influence of Venus and Mars in the cognitive sky of schizophrenia. Results from the first-step national FACE-SZ cohort.
Fond G; Boyer L; Leboyer M; Godin O; Llorca PM; Andrianarisoa M; Berna F; Brunel L; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Mallet J; Misdrahi D; Rey R; Lancon C; Passerieux C; Roux P; Vidailhet P; Yazbek H; Schürhoff F; Bulzacka E;
Schizophr Res; 2018 May; 195():357-365. PubMed ID: 28974404
[TBL] [Abstract][Full Text] [Related]
11. Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.
Asevedo E; Gadelha A; Noto C; Mansur RB; Zugman A; Belangero SI; Berberian AA; Scarpato BS; Leclerc E; Teixeira AL; Gama CS; Bressan RA; Brietzke E
J Psychiatr Res; 2013 Oct; 47(10):1376-82. PubMed ID: 23806580
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological impairment in deficit vs. non-deficit schizophrenia.
Cascella NG; Testa SM; Meyer SM; Rao VA; Diaz-Asper CM; Pearlson GD; Schretlen DJ
J Psychiatr Res; 2008 Sep; 42(11):930-7. PubMed ID: 18021807
[TBL] [Abstract][Full Text] [Related]
13. Measuring Cognition in Bipolar Disorder with Psychosis Using the MATRICS Consensus Cognitive Battery.
Sperry SH; O'Connor LK; Öngür D; Cohen BM; Keshavan MS; Lewandowski KE
J Int Neuropsychol Soc; 2015 Jul; 21(6):468-72. PubMed ID: 26154947
[TBL] [Abstract][Full Text] [Related]
14. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
[TBL] [Abstract][Full Text] [Related]
16. Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial.
Stroup S; Appelbaum P; Swartz M; Patel M; Davis S; Jeste D; Kim S; Keefe R; Manschreck T; McEvoy J; Lieberman J
Schizophr Res; 2005 Dec; 80(1):1-8. PubMed ID: 16182516
[TBL] [Abstract][Full Text] [Related]
17. Reduction of cortical GABAergic inhibition correlates with working memory impairment in recent onset schizophrenia.
Takahashi S; Ukai S; Kose A; Hashimoto T; Iwatani J; Okumura M; Tsuji T; Shinosaki K
Schizophr Res; 2013 May; 146(1-3):238-43. PubMed ID: 23523695
[TBL] [Abstract][Full Text] [Related]
18. Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study.
Olivier MR; Killian S; Chiliza B; Asmal L; Schoeman R; Oosthuizen PP; Kidd M; Emsley R
Psychol Med; 2015 Oct; 45(13):2873-83. PubMed ID: 25998030
[TBL] [Abstract][Full Text] [Related]
19. Relationship between effortful motivation and neurocognition in schizophrenia.
Bismark AW; Thomas ML; Tarasenko M; Shiluk AL; Rackelmann SY; Young JW; Light GA
Schizophr Res; 2018 Mar; 193():69-76. PubMed ID: 28673753
[TBL] [Abstract][Full Text] [Related]
20. Correlating cognitive functions to symptom domains and insight in Egyptian patients with schizophrenia.
Khalil AH; El-Meguid MA; Bastawy M; Rabei S; Ali R; Abd Elmoneam MHE
Int J Soc Psychiatry; 2020 May; 66(3):240-248. PubMed ID: 31928181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
